Streamlining Drug Development and Improving Patient Care: CDER Quantitative Medicine Center of Excellence

https://www.fda.gov/drugs/cder-conversations/streamlining-drug-development-and-improving-patient-care-cder-quantitative-medicine-center?utm_medium=email&utm_source=govdelivery CDER Conversation: Streamlining Drug Development and Improving Patient Care: CDER Quantitative Medicine Center of Excellence In this CDER Conversation, Rajanikanth Madabushi, lead for CDER’s Quantitative Medicine (QM) Center of Excellence (CoE) and associate director for Guidance and Scientific Policy in the Office of Clinical Pharmacology in the Office of Translational Science Super Office explains the purpose of the new CoE, provides an overview of current activities and resources, and shares ways the CoE can advance drug development and improve patient care.